Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Sage Therapeutics (SAGE) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 24 quarters since 2015. Compare with SAGE stock chart to see long term trends.

SAGE stock compared to

SAGE Income Statement

Revenue, Net:1109186000
Revenue Per Share:21.34
Selling, General & Admin Expense:53499000
Research & Development Expense:81706000
Total Operating Expenses:135211000
Operating Income:983822000
Net Income:974895000
Earnings Per Share, Basic:18.76
Shares Outstanding, Basic Avg:51983188

SAGE Cash Flow

Operating Activities Net Income:
Net Cash from Operations:1010971000
Net Cash from Financing Activities:419671000
Property, Plant & Equipment Purchases:0
Net Cash from Investing Activities:45519000
Net Change in Cash & Equivalents:1476161000

SAGE Balance Sheet

Cash and Cash Equivalents:1662798000
Short-Term Investments:438467000
Total Current Assets:2122370000
Property, Plant & Equipment, Net:6755000
Total Assets:2159246000
Accounts Payable:3691000
Total Short-Term Liabilities:67204000
Total Liabilities:86912000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
FMR LLC
7,796,140 sh
8,468 sh
0%
$476,500
$152,689
Vanguard Group Inc
4,520,440 sh
-212,592 sh
-4%
$276,290
$79,491
Blackrock Inc.
2,993,856 sh
-191,457 sh
-6%
$182,985
$50,538
Price T Rowe Associates Inc /Md/
2,559,034 sh
-260,018 sh
-9%
$156,408
$39,192
D. E. Shaw & Co., Inc.
2,463,066 sh
2,433,066 sh
8110%
$150,543
$149,296
Great Point Partners LLC
1,966,688 sh
-135,680 sh
-6%
$120,204
$32,788
Invesco Ltd.
1,494,886 sh
-243,522 sh
-14%
$91,367
$19,085
Boxer Capital, LLC
1,094,000 sh
 
$66,865
Farallon Capital Management LLC
1,050,000 sh
200,000 sh
24%
$64,176
$28,833
Goldman Sachs Group Inc
533,235 sh
-279,550 sh
-34%
$32,591
-$1,204
UBS Asset Management Americas Inc
445,375 sh
4,529 sh
1%
$27,221,319
$8,890,943
Ameriprise Financial Inc
389,996 sh
17,380 sh
5%
$23,827
$8,330
Northern Trust Corp
299,437 sh
-5,985 sh
-2%
$18,301
$5,602
Morgan Stanley
265,729 sh
113,109 sh
74%
$16,241
$9,896
Jacobs Levy Equity Management, Inc
258,819 sh
2,544 sh
1%
$15,819
$5,163
Charles Schwab Investment Management Inc
255,889 sh
2,973 sh
1%
$15,640
$5,123
Wellington Management Group Llp
238,508 sh
94,161 sh
65%
$14,578
$8,577
Amundi Pioneer Asset Management Inc
223,133 sh
37,343 sh
20%
$13,638
$5,913
Artal Group S.A.
222,300 sh
-11,700 sh
-5%
$13,587
$3,857
American Century Companies Inc
220,004 sh
239 sh
0%
$13,447
$4,309

Data imported from Sage Therapeutics Inc SEC filings. Check original filings before making any investment decision.